Halometasone monohydrate (0.05%) in occupational contact dermatitis | Zendy

Rituparna Maiti | Zendy; ChandraSekhar Sirka | Zendy; Noel Shaju | Zendy; Debasish Hota | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Halometasone monohydrate (0.05%) in occupational contact dermatitis

Author(s) -

Rituparna Maiti,

ChandraSekhar Sirka,

Noel Shaju,

Debasish Hota

Publication year - 2016

Publication title -

indian journal of pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.286

H-Index - 59

eISSN - 1998-3751

pISSN - 0253-7613

DOI - 10.4103/0253-7613.178823

Subject(s) - medicine , scorad , dermatology , atopic dermatitis , dermatology life quality index , quality of life (healthcare) , allergic contact dermatitis , allergy , immunology , nursing , psoriasis

The impact of occupational contact dermatitis (OCD) is often underestimated because of underreporting, and its management is also inadequate, especially in developing countries. Topical corticosteroids have remained the first line treatment but till date, there is no study on efficacy and safety of halometasone in OCD, and there is a paucity of data on its comparative efficacy in allergic and irritant variety. This study aims to evaluate the efficacy and safety of halometasone in OCD and to compare its effect in allergic and irritant types of OCD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research